The dye, a compound called orcein, and the related substance O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer’s disease. O4 binding to small aggregates promotes their conversion into large, mature plaques which researchers from the Max Delbrück Center (MDC) and the Charité – Universitätsmedizin Berlin in Germany assume to be largely non-toxic for neuronal cells (Nature Chemical Biology, doi: http://dx.doi.org/10.1038/NCHEMBIO.719)*.
Further research with animal models is needed to determine whether this new approach by Dr. Jan Bieschke (MDC), Dr. Martin Herbst (Charité) and Professor Erich Wanker (MDC) will be useful for therapy development.
Protein misfolding is considered to be the cause of Alzheimer’s, Parkinson’s and also Huntington’s disease. In a multistep process, proteins misfold and accumulate into large extra- or intracellular plaques. Researchers assume that small misfolded protein aggregates that are precursors of mature plaques are toxic for nerve cells and are the reason why they are eventually destroyed.
“This is a new mechanism,” Professor Wanker explained. “Up to now it has been considered to be very difficult to stop the formation of small toxic protein assemblies. If our hypothesis is correct that the small aggregates, which are precursors of plaques, indeed cause neuronal death, with O4 we would have a new mechanism to attack the disease.”
The synthetic dye methylene blue is currently being tested in clinical trials. This dye also seems to stimulate the formation of large plaques in a way similar to O4. Other therapeutic approaches tested in clinical trials which aim at eliminating small precursor aggregates have so far not led to a significant improvement of disease symptoms.
However, it still remains to be seen whether the blue dye O4 can also be effective against small amounts of misfolded proteins in the brains of Alzheimer’s patients and whether the accelerated formation of larger plaques can indeed reduce the signs and symptoms of Alzheimer’s disease in humans. Further studies will be necessary to address the question whether the accelerated formation of large plaques can be a therapeutic approach. “We hope that our findings will stimulate research activities in this direction, especially in drug discovery,” Professor Wanker said.*Small-molecule conversion of toxic oligomers to nontoxic b-sheet–rich amyloid fibrils
Jan Bieschke1,12, Martin Herbst1,2,12, Thomas Wiglenda1, Ralf PFriedrich1, Annett Boeddrich1, Franziska Schiele1, Daniela Kleckers1, Juan Miguel Lopez del Amo3, Björn Grüning4, Qinwen Wang5,11, Michael RSchmidt1, Rudi Lurz6, Roger Anwyl5, Sigrid Schnoegl1, Marcus Fändrich7, Ronald F Frank8, Bernd Reif3,9, Stefan Günther4, Dominic M Walsh10 & Erich EWanker1
1Neuroproteomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany. 2Department of Neurology, Charité-Universitätsmedizin Berlin, Germany. 3Leibniz Institute for Molecular Pharmacology, Berlin, Germany. 4Institute for Pharmaceutical Sciences, University of Freiburg, Germany. 5Department of Physiology, School of Medicine, Trinity College, Dublin, Republic of Ireland, 6Max Planck Institute for Molecular Genetics, Berlin, Germany. 7Max Planck Research Unit for Enzymology of Protein Folding, Halle (Saale), Germany. 8Department of Chemistry, Helmholtz Center for Infection Research, Braunschweig, Germany. 9Technical University Munich, Munich, Germany. 10Laboratory for Neurodegenerative Research, The Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Republic of Ireland. 11Present address: Department of Physiology and Pharmacology, Medical School, Ningbo University, Ningbo, China. 12These authors contributed equally to this work.Barbara Bachtler
Barbara Bachtler | Max-Delbrück-Centrum
Switch-in-a-cell electrifies life
18.12.2018 | Rice University
Plant biologists identify mechanism behind transition from insect to wind pollination
18.12.2018 | University of Toronto
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
18.12.2018 | Materials Sciences
18.12.2018 | Physics and Astronomy
18.12.2018 | Physics and Astronomy